Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is moving forward with the pre-conditional privatization of Henlius, as updated in their latest announcements. While working towards the fulfillment of non-waivable prerequisites, the company is in active liaison with PRC regulatory bodies. However, the dispatch of the detailed Composite Document to shareholders has been delayed.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
